No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” By Jorge L. Moderna’s Pledge.
362 
Let's personalize your content